ACHL News and Press, Achilles Therapeutics plc From 06/30/22

LONDON, June 30, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced the appointment of James Taylor as Chief Business Officer and Cassian Yee, MD to its Sc...

LONDON, June 21, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that the Company was named the winner of the Pharmaceutical Industry Network Group (PIN...

Achilles Therapeutics press release (NASDAQ:ACHL): Q1 GAAP EPS of -$0.45 beats by $0.06. Cash and cash equivalents were $236.9 million as of March 31, 2022, as compared to $266.3 million as of December 31, 2021. The Company anticipates that its cash and cash equivalents are sufficient to fund...

- Dosed first patient with higher-dose (Process 2) cNeT for advanced NSCLC (CHIRON) and initiated enrollment of cNeT + PD-1 inhibitor combination (THETIS Cohort B) for metastatic malignant melanoma - - Expanded global manufacturing by increasing capacity in the UK and establishing a U...

- THETIS Cohort B enrollment follows positive Independent Data Safety Monitoring Committee review - - Monotherapy data from higher-dose cohorts in both CHIRON and THETIS and combination data from THETIS Cohort B expected in 2H 2022 - LONDON, May 09, 2022 (GLOBE NEWSWIRE) -- Achill...

LONDON, May 04, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced the appointment of Bernhard Ehmer, MD, to the Board as a Non-Executive Director. Bernhar...

The following slide deck was published by Achilles Therapeutics plc in conjunction with this event. For further details see: Corporate Presentation April 2022

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Gainers:Singular Genomics Systems  (OMIC) +5%. Sonos  (SONO) +5%. Fulton Financial Corporation (FULT) +5%. CytomX Therapeutics (CTMX) +5%. Walgreens Boots Alliance (WBA) +4%. Losers: Netflix (NFLX) -26%. LifeStance Health Group (LFST) -8%. INMODE  (INMD) -8%. Rok...

The Center for Breakthrough Medicines (CBM) Strikes Multi-Year Deal with UK Cell Therapy Powerhouse PR Newswire Strategic Partnership to Deliver US Based Manufacturing Capacity for Novel Cell Therapy KING OF PRUSSIA, Pa. , April 12, 2022 /PRNewswire/ ...